These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 16632014)

  • 21. Predicting progression in IgA nephropathy.
    Bartosik LP; Lajoie G; Sugar L; Cattran DC
    Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive IgA nephropathy: the role of hypertension.
    Payton CD; McLay A; Jones JM
    Nephrol Dial Transplant; 1988; 3(2):138-42. PubMed ID: 3140079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
    Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette smoking and progression of IgA nephropathy.
    Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
    Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Some metabolic and genetic risk factors and the progression of IgA nephropathy--preliminary report].
    Sulikowska B; Czarny J; Rość D; Odrowaz-Sypniewska G; Manitius J; Sliwka DM
    Pol Merkur Lekarski; 2006 Aug; 21(122):132-5; discussion 136. PubMed ID: 17144095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of primary IgA nephropathy.
    Berthoux FC; Mohey H; Afiani A
    Semin Nephrol; 2008 Jan; 28(1):4-9. PubMed ID: 18222341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T; Fernando ME; Jayakumar M
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
    Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin A nephropathy and chronic kidney disease.
    Tomino Y
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():23-6. PubMed ID: 20586943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [IgA nephropathy].
    Alamartine E
    Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum complement proteins in IgA nephropathy.
    Julian BA; Wyatt RJ; McMorrow RG; Galla JH
    Clin Nephrol; 1983 Nov; 20(5):251-8. PubMed ID: 6606518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenetic differences in subpopulations of patients with IgA nephropathy (Berger's disease).
    Ockhuizen T; Beukhof JR; Westra J; Halie LM; Beelen JM; van der Hem GK
    Exp Clin Immunogenet; 1984; 1(3):121-8. PubMed ID: 6401001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.